Omnicell

Since 1992, Omnicell has been creating innovative solutions to improve patient care, anywhere it is delivered. The Company is a leading supplier of comprehensive automation and business analytics software for medication and supply management across the entire healthcare continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities, to the patient’s home. A lot of customers worldwide use Omnicell automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. The acquisition of Aesynt adds distinct capabilities, particularly in central pharmacy and IV robotics, creating the broadest medication management product portfolio in the industry. The Omnicell SureMed solution provides innovative medication adherence packaging to help reduce costly hospital readmissions.
Type
Public
HQ
Mountain View, US
Founded
1992
Size (employees)
2,444 (est)
Omnicell was founded in 1992 and is headquartered in Mountain View, US

Omnicell Office Locations

Omnicell has offices in Mountain View, Milpitas, Saint Petersburg, Waukegan and in 2 other locations
Mountain View, US (HQ)
590 E Middlefield Rd
Warrendale, US
400 51 Pennwood Pl
Cranberry Township, US
500 Cranberry Woods Dr
Waukegan, US
Burwood Drive
Saint Petersburg, US
2003 Gandy Blvd N
Milpitas, US
725 Sycamore Dr

Omnicell Data and Metrics

Omnicell Financial Metrics

Omnicell's revenue was reported to be $692.6 m in FY, 2016 which is a 43% increase from the previous period.
USD

Revenue (FY, 2016)

692.6 m

Revenue growth (FY, 2015 - FY, 2016), %

43%

Gross profit (FY, 2016)

313.8 m

Gross profit margin (FY, 2016), %

45%

Net income (FY, 2016)

603 k

EBIT (FY, 2016)

6.5 m

Market capitalization (23-Jun-2017)

1.7 b

Closing share price (23-Jun-2017)

43.9

Cash (31-Dec-2016)

54.5 m
Omnicell's current market capitalization is $1.7 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

380.6 m440.9 m484.6 m692.6 m

Revenue growth, %

16%10%43%

Cost of goods sold

177.2 m207 m236.6 m378.8 m

Gross profit

203.4 m233.9 m247.9 m313.8 m

Gross profit Margin, %

53%53%51%45%

Operating expense total

168.1 m184.3 m199.3 m307.3 m

EBIT

35.3 m49.6 m48.6 m6.5 m

EBIT margin, %

9%11%10%1%

Interest income

270 k2.4 m8.4 m

Pre tax profit

35 m48.5 m46.2 m

Income tax expense

11.1 m18 m15.5 m(2.6 m)

Net Income

24 m30.5 m30.8 m603 k
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

104.5 m125.9 m82.2 m54.5 m

Inventories

31.5 m46.6 m69.3 m

Current Assets

233.8 m283.4 m264.1 m315.4 m

PP&E

35.3 m36.2 m32.3 m42 m

Goodwill

111.3 m122.7 m147.9 m327.7 m

Total Assets

492.5 m560.2 m578.7 m935.1 m

Accounts Payable

16.5 m19.4 m22.6 m27.1 m

Current Liabilities

92.4 m112.3 m124.6 m180.9 m

Additional Paid-in Capital

421.2 m457.4 m490.4 m525.8 m

Retained Earnings

38.5 m69 m99.8 m100.4 m

Total Equity

349 m402.4 m431.6 m

Financial Leverage

1.4 x1.4 x2.2 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

24 m30.5 m30.8 m603 k

Depreciation and Amortization

18.4 m20.3 m25.6 m58.4 m

Accounts Receivable

(3.6 m)(23 m)(18 m)8 m

Inventories

(5.4 m)1.4 m(10 m)(3.4 m)

Accounts Payable

(1.8 m)1.6 m(2.8 m)(5 m)

Cash From Operating Activities

42.2 m65.2 m33.8 m47.9 m

Purchases of PP&E

(12.3 m)(11.9 m)(7.5 m)(13.4 m)

Cash From Investing Activities

(20.5 m)(43.3 m)(45.6 m)(341.3 m)

Cash From Financing Activities

(206 k)(31.8 m)265.7 m

Interest Paid

122 k61 k76 k5.3 m

Income Taxes Paid

7.1 m
Y, 2016

Financial Leverage

2.2 x

Omnicell Market Value History

Omnicell Median Salaries

Source: 106 public H-1B filings from Omnicell

Omnicell Online and Social Media Presence

Omnicell Company Life and Culture

You may also be interested in